NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001930

Registered date:01/05/2009

Clinical study of alpha-GalactosylCeramide-pulsed DC therapy in Patients with Head and Neck Malignant Melanoma after the Charged Particle Radiotherapy

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedHead and Neck Malignant Melanoma
Date of first enrollment2008/04/01
Target sample size20
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Sub-mucosal administrations of alpha-GalactosylCeramide pulsed DCs are performed on day 7, 14, 56 and day63 after the entry.

Outcome(s)

Primary OutcomeSafety
Secondary OutcomeThe clinical effects and immunological responses

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriaPatients who have: uncontrolled diabetes mellitus, pulmonary fibrosis, and/or infection; a history of hepatitis; a positive response for hepatitis B surface antigen, or human immunodeficiency virus (HIV), hepatitis C virus, or human T-lymphotrophic virus antibodies; serious cardiac disease; recieived concurrent corticosteroid therapy; pregnancy or lactation; autoimmune diseases; been judged to be inappropriate to participate in this study by principle investigator or co-investigator

Related Information

Contact

public contact
Name Shigetoshi Horiguchi
Address 1-8-1 Inohana, Chuo-ku, Chiba, Japan Japan
Telephone
E-mail
Affiliation Graduate School of Medicine, Chiba University epartment of Otorhinolaryngology, Head and Neck Surgery
scientific contact
Name Yoshitaka Okamoto
Address 1-8-1 Inohana, Chuo-ku, Chiba, Japan Japan
Telephone
E-mail
Affiliation Graduate School of Medicine, Chiba University Department of Otorhinolaryngology, Head and Neck Surgery